| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Holler Frank A is a Director at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2021 | XENE Xenon Pharmaceuticals Inc. | Director | Sale+OE | 11,064 | $18.68 | $206,701.31 | -3.6% | -10.1% | +45.4% | |
| Sep 20, 2019 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 12,806 | $9.32 | $119,336.34 | -5.0% | - | - | |
| Sep 18, 2019 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 9,437 | $9.30 | $87,778.12 | -3.4% | - | - | |
| Dec 15, 2016 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 30,000 | $7.85 | $235,500.00 | -20.6% | - | - | |
| Aug 19, 2016 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 11,938 | $7.65 | $91,337.64 | -7.6% | - | - | |
| Aug 18, 2016 | XENE Xenon Pharmaceuticals Inc. | Director | Sell | 18,062 | $7.93 | $143,156.05 | -3.5% | - | - |